N-terminal-pro brain natriuretic peptide levels in children with allergic rhinitis

dc.authoridVatansev, Husamettin/0000-0002-0230-3414
dc.authoridARTAC, HASIBE/0000-0002-9807-2605
dc.authoridKAYIS, Seyit Ali/0000-0003-4791-8946
dc.contributor.authorArtac, Hasibe
dc.contributor.authorVatansev, Husamettin
dc.contributor.authorCimen, Derya
dc.contributor.authorArslan, Derya
dc.contributor.authorKaya, Fatma
dc.contributor.authorKayis, Seyit Ali
dc.contributor.authorOran, Bulent
dc.date.accessioned2024-09-29T16:08:21Z
dc.date.available2024-09-29T16:08:21Z
dc.date.issued2016
dc.departmentKarabük Üniversitesien_US
dc.description.abstractBackground/aim: Persistent upper airway obstruction may lead to increased pulmonary arterial pressure (PAP). The aim of this study was to evaluate N-terminal pro brain natriuretic peptide (NT-proBNP) concentrations and PAP values in children with allergic rhinitis. Materials and methods: Sixty-six patients with allergic rhinitis and 22 healthy children were prospectively enrolled in this study. Plasma NT-proBNP levels were measured at first admission and after treatment. Simultaneously, echocardiography was done to assess pulmonary arterial hypertension, and rhinitis symptom scores were recorded. Results: The median age of the study group was 9.0 (5.0. 17.0) years; 26 were female. PAP was found to be normal in all the patients. There was a negative correlation between age and NT-proBNP levels (r = -0.452, P < 0.01). Nasal blockage levels affected NT-proBNP levels mildly (P = 0.067). No significant difference between before and after nasal steroid treatment was observed in NT-proBNP levels. Conclusion: These results suggest that NT-proBNP level and PAP may not be affected in children with allergic rhinitis, and primarily this influence may be associated with the severity of nasal obstruction.en_US
dc.identifier.doi10.3906/sag-1502-143
dc.identifier.endpage1134en_US
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue4en_US
dc.identifier.pmid27513415en_US
dc.identifier.scopus2-s2.0-84975842674en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1130en_US
dc.identifier.urihttps://doi.org/10.3906/sag-1502-143
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7504
dc.identifier.volume46en_US
dc.identifier.wosWOS:000378646700028en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTubitak Scientific & Technological Research Council Turkeyen_US
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAllergic rhinitisen_US
dc.subjectpulmonary arterial pressureen_US
dc.subjectN-terminal pro B-type natriuretic peptideen_US
dc.subjectnasal obstructionen_US
dc.subjectcardiac evaluationen_US
dc.titleN-terminal-pro brain natriuretic peptide levels in children with allergic rhinitisen_US
dc.typeArticleen_US

Dosyalar